As of June 4, 2025, InnovAge Holding Corp (INNV) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing InnovAge Holding Corp's Forward P/E to Peers
To better understand InnovAge Holding Corp's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| InnovAge Holding Corp (INNV) | - |
| Amedisys Inc (AMED) | 19.63 |
| Quest Diagnostics Inc (DGX) | 17.46 |
| Laboratory Corporation of America Holdings (LH) | 15.10 |
| DaVita Inc (DVA) | 12.10 |
| Cigna Group (CI) | 10.40 |
Compared to its competitors, InnovAge Holding Corp's Forward P/E is difficult to compare due to insufficient data.